Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …
Biotechnology
US, Cambridge [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -72.00 | -84.00 | -87.00 | -115.00 | -68.00 | -165.00 | -189.00 | -307.00 | -382.00 | -562.00 | -278.00 | -614.00 | -641.00 | -541.00 | 104.00 | |
| Operating Cash (Net) | -72.00 | -84.00 | -87.00 | -115.00 | -68.00 | -165.00 | -189.00 | -307.00 | -382.00 | -562.00 | -278.00 | -614.00 | -641.00 | -541.00 | 104.00 | |
| Accounts Receivable | - - | - - | - - | 1.00 | -4.00 | -35.00 | 31.00 | -15.00 | -10.00 | 15.00 | -24.00 | -56.00 | -101.00 | -45.00 | -87.00 | |
| Accounts Payable | 9.00 | -3.00 | -3.00 | -1.00 | 1.00 | 8.00 | 1.00 | 10.00 | -4.00 | 15.00 | 36.00 | 117.00 | 88.00 | 191.00 | 80.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -50.00 | -79.00 | -55.00 | -8.00 | -8.00 | -29.00 | 35.00 | 17.00 | -2.00 | 45.00 | 402.00 | -12.00 | -162.00 | -35.00 | 10.00 | |
| Other WC | -60.00 | -76.00 | -52.00 | -6.00 | -5.00 | -5.00 | 2.00 | 16.00 | 1.00 | 37.00 | 422.00 | -38.00 | -122.00 | -147.00 | - - | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | 14.00 | 17.00 | 81.00 | 3.00 | -130.00 | -548.00 | -321.00 | 142.00 | -290.00 | 272.00 | -417.00 | -435.00 | -273.00 | 169.00 | -336.00 | |
| Capital Expenditure | -4.00 | -4.00 | -1.00 | -8.00 | -4.00 | -8.00 | -12.00 | -64.00 | -104.00 | -126.00 | -140.00 | -70.00 | -76.00 | -72.00 | -62.00 | |
| Purchases of Investments | -481.00 | -390.00 | -293.00 | -277.00 | -364.00 | -977.00 | -1,033.00 | -759.00 | -903.00 | -1,104.00 | -2,075.00 | -2,025.00 | -1,656.00 | -1,976.00 | -1,881.00 | |
| Sale/Maturity of Investment | 504.00 | 413.00 | 376.00 | 289.00 | 237.00 | 462.00 | 726.00 | 1,116.00 | 597.00 | 1,518.00 | 1,775.00 | 1,691.00 | 1,463.00 | 2,231.00 | 1,612.00 | |
| Property, Plant, Equipment (P&PE) | -4.00 | -4.00 | -1.00 | -8.00 | -4.00 | -8.00 | -12.00 | -64.00 | -104.00 | -126.00 | -140.00 | -70.00 | -76.00 | -72.00 | -62.00 | |
| Acquisitions (Net) | -10.00 | -17.00 | -81.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | 6.00 | 17.00 | 81.00 | - - | - - | -25.00 | -1.00 | -150.00 | 120.00 | -14.00 | 23.00 | -31.00 | -4.00 | -13.00 | -4.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -3.00 | -3.00 | - - | -93.00 | -200.00 | -736.00 | -616.00 | -177.00 | -1,124.00 | -65.00 | -823.00 | -994.00 | -1,247.00 | -425.00 | -172.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | -120.00 | - - | -30.00 | -686.00 | -1,000.00 | -762.00 | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | 87 | 1 | 15 | - - | 14 | 1,161 | 3 | - - | - - | - - | - - | - - | |
| Issued | 3.00 | 3.00 | - - | 86.00 | - - | - - | - - | 14.00 | 1,161.00 | - - | 853.00 | 99.00 | 246.00 | 259.00 | 147.00 | |
| Repurchased | - - | - - | - - | - - | -1.00 | -15.00 | - - | - - | - - | -3.00 | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | - - | - - | 6.00 | 202.00 | 752.00 | 616.00 | 164.00 | 84.00 | 68.00 | 823.00 | 1,582.00 | 2,000.00 | 928.00 | 24.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 191.00 | 137.00 | 74.00 | 70.00 | 51.00 | 53.00 | 75.00 | 180.00 | 193.00 | 646.00 | 422.00 | 549.00 | 499.00 | 822.00 | 866.00 | |
| End of Period | 137.00 | 74.00 | 70.00 | 51.00 | 53.00 | 75.00 | 180.00 | 193.00 | 645.00 | 422.00 | 549.00 | 499.00 | 822.00 | 868.00 | 812.00 | |
| Change | -54.00 | -62.00 | -4.00 | -18.00 | 1.00 | 22.00 | 105.00 | 12.00 | 451.00 | -224.00 | 126.00 | -50.00 | 323.00 | 46.00 | -53.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 5.00 | 4.00 | 5.00 | 9.00 | 10.00 | 11.00 | 19.00 | 15.00 | 13.00 | 6.00 | 54.00 | 74.00 | 89.00 | 85.00 | 54.00 | |
| Stock Based Compensation | 20.00 | 19.00 | 16.00 | 12.00 | 20.00 | 33.00 | 45.00 | 75.00 | 92.00 | - - | 174.00 | 139.00 | 165.00 | 230.00 | 221.00 | |
| Other | 4.00 | 3.00 | 1.00 | - - | - - | 221.00 | - - | 1.00 | 2.00 | -6.00 | -12.00 | 95.00 | 174.00 | 309.00 | 657.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -77.00 | -89.00 | -88.00 | -123.00 | -72.00 | -174.00 | -202.00 | -372.00 | -486.00 | -689.00 | -418.00 | -685.00 | -718.00 | -613.00 | 41.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | - - | - - | - - | -7,127.00 | 165.00 | 264.00 | 214.00 | 150.00 | 104.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 4.00 | -9.00 | -7.00 | 6.00 |